Tachykinin receptor antagonists: Potential in airways diseases

Current Opinion in Pharmacology

Volumn 1, Issue 3, 2001, Pages 235-241

  Joos, Guy F ^a   Pauwels, Romain A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Airway inflammation; Asthma; Chronic obstructive pulmonary disease; Immunology; Molecular Medicine; Neurokinin A; Pharmacology; Sensory neuropeptides; Substance P; Tachykinin receptor antagonists

Indexed keywords

TACHYKININ; TACHYKININ RECEPTOR;

ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; GENETICS; HUMAN; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW;

ANIMALS; HUMANS; RECEPTORS, TACHYKININ; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; TACHYKININS;

EID: 0035381322     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00042-X     Document Type: Review

References (66)

1. Joos G.F., Germonpre P.R., Pauwels R.A. Role of tachykinins in asthma. Allergy. 55:2000;321-337.
2. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev. 48:1996;113-178.
3. Tomaki M., Ichinose M., Miura M., Hirayama Y., Yamauchi H., Nakajima N., Shirato K. Elevated Substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med. 151:1995;613-617.
4. Cardell L.O., Uddman R., Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J. 7:1994;2169-2173.
5. Heaney L.G., Cross L.J.M., McGarvey L.P.A., Buchanan K.D., Ennis M., Shaw C. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax. 53:1998;357-362.
6. Krishna M.T., Springall D.R., Meng Q.-H., Whiters N., Macleod D., Biscione G., Frew A., Polak J., Holgate S. Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med. 156:1997;943-950.
7. Baraniuk J.N., Ali M., Yuta A., Fang S.Y., Naranch K. Hypertonic saline nasal provocation stimulates nociceptive nerves, Substance P release, and glandular mucous exocytosis in normal humans. Am J Respir Crit Care Med. 160:1999;655-662.
8. Joos G.F., Pauwels R.A. Pro-inflammatory effects of Substance P: new perspectives for the treatment of airway diseases? Trends Pharmacol Sci. 21:2000;131-133.
9. 1 receptor expression in U-937 cells.
10. 1 receptor antagonist to the mixed leukocyte reaction induced by dendritic cells, partially inhibited T-cell proliferation. Thus, dendritic cells have the capacity to produce SP as part of their co-stimulatory activity for lymphocytes.
11. Fischer A., McGregor G.P., Saria A., Phillippin B., Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest. 98:1996;2284-2291.
12. Bonini S., Lambiase A., Levi-Schaffer F., Aloe L. Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int Arch Allergy Immunol. 118:1999;159-162.
13. Braun A., Lommatzsch M., Renz H. The role of neurotrophins in allergic bronchial asthma. Clin Exp Allergy. 30:2000;178-186.
14. Virchow J.C., Julius P., Lommatzsch M., Luttmann W., Renz H., Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med. 158:1998;2002-2005.
15. Hoyle G.W., Graham R.G., Finkelstein J.B., Thi Nguyen K.-P., Gozal D., Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol. 18:1998;149-157.
16. Hunter D.D., Myers A.C., Undem B.J. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med. 161:2000;1985-1990. Injection of NGF in the guinea pig tracheal wall increased the number of nodose and jugular neurones containing SP. Moreover, production of SP was induced in large-diameter capsaicin-insensitive neurones innervating the airways that were previously negative for SP immunoreactivity. NGF, therefore, not only increases the percentage of airway-specific sensory neurones expressing SP, but also leads to a phenotypic switch in the nature of vagal sensory neurones producing SP.
17. Knight D.A., Lydell C.P., Zhou D., Weir T.D., Schellenberg R.R., Bai T.R. Leukemia inhibitory factor (LIF) and LIF receptor in human lung - distribution and regulation of LIF release. Am J Respir Cell Mol Biol. 20:1999;834-841.
18. Knight D.A., D'Aprile A.C., Spalding L.J., Goldie R.G., Thompson P.J. Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants. Br J Pharmacol. 130:2000;975-979.
19. Ollerenshaw S.L., Jarvis D., Sullivan C.E., Woolcock A.J. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J. 4:1991;673-682.
20. Howarth P.H., Springall D.R., Redington A.E., Djukanovic R., Holgate S., Polak J. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol. 3:1995;288-296.
21. Chanez P., Springall D.R., Vignola A., Moradoghi-Hattvani A., Polak J., Godard P., Bousquet J. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med. 158:1998;985-990.
22. 1 receptor staining was associated with the detection of Mycoplasma pneumoniae in BAL fluid and/or biopsy tissue. More studies are needed to confirm these novel findings and to delineate the effect of viral or mycoplasma infections on the peptide content of neurones innervating the airways.
23. Lucchini R.E., Facchini F., Turato G., Saetta M., Caramori G., Ciaccia A., Maestrelli P., Springall D.R., Polak J.M., Fabbri L., Mapp C.E. Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis. Am J Respir Crit Care Med. 156:1997;1963-1968.
24. O'Connell F., Springall D.R., Moradoghli-Haftvani A., Krausz T., Price D., Fuller R.W., Polak J.M., Pride N.B. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am J Respir Crit Care Med. 152:1995;2068-2075.
25. Maggi C.A. The troubled story of tachykinins and neurokinins. Trends Pharmacol Sci. 21:2000;173-175.
26. Advenier C., Joos G., Molimard M., Lagente V., Pauwels R. Role of tachykinins as contractile agonists of human airways in asthma. Clin Exp Allergy. 29:1999;579-584.
27. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., Kawashima E. Molecular characterisation, expression and localisation of human neurokinin-3 receptor. FEBS Lett. 299:1992;90-95.
28. Canning B.J., Fischer A., Undem B.J. Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. J Pharmacol Exp Ther. 284:1998;370-377.
29. 3 receptors in citric-acid-induced cough and bronchial responses in guinea pigs. Am J Respir Crit Care Med. 158:1998;42-48.
30. 3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig. Br J Pharmacol. 130:2000;49-56.
31. 2)-receptor gene expression in inflammatory airway disease. Am J Physiol. 269:1995;L309-L317.
32. Adcock I.M., Peters M., Gelder C., Shirasaki H., Brown C.R., Barnes P.J. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol. 11:1993;1-7.
33. 2 receptor in normal airways and the airways of smokers. It is not known what changes in expression of these receptors occur in asthmatic airways.
34. Snider R.M., Constantine J.W., Lowe J.A. I.I.I., Longo K.P., Lebel W.S., Woody H.A., Drzda S.E., Desai M.C., Vinick F.J., Spence R.W., Hess H.J. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 251:1991;435-437.
35. Emonds-Alt X., Vilain P., Goulaouic P., Proietto V., van Broeck D., Advenier C., Naline E., Neliat G., le Fur G., Breliere J.C. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci. 50:1992;L101-L106.
36. Bertrand C., Geppetti P., Graf P.D., Foresi A., Nadel J.A. Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pigs. Am J Physiol. 265:1993;L507-L511.
37. Bertrand C., Geppetti P., Baker J., Yamawaki I., Nadel J.A. Role of neurogenic inflammation in antigen-induced vascular extravasation in guinea pig trachea. J Immunol. 150:1993;1479-1485.
38. Kudlacz E.M., Knippenberg R.W., Logan D.E., Burkholder T.P. Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model. J Pharmacol Exp Ther. 279:1996;732-739.
39. Schuiling M., Zuidhof A., Zaagsma J., Meurs H. Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea-pigs. Am J Respir Crit Care Med. 159:1999;423-430.
40. Schuiling M., Zuidhof A., Meurs H., Zaagsma J. Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammation cell influx in conscious, unrestrained guinea-pigs. Br J Pharmacol. 127:1999;1030-1038.
41. Maghni K., Taha R., Afif W., Hamid Q., Martin J.G. Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation. Am J Respir Crit Care Med. 162:2000;1068-1074.
42. Ichinose M., Nakajima N., Takahashi T., Yamauchi H., Inoue H., Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet. 340:1992;1248-1251.
43. Schmidt D., Jorres R.A., Rabe K.F., Magnussen H. Reproducibility of airway response to inhaled bradykinin and effect of the neurokinin receptor antagonist FK-224 in asthmatic subjects. Eur J Clin Pharmacol. 50:1996;269-273.
44. Joos G.F., van Schoor J., Kips J.C., Pauwels R.A. The effect of inhaled FK244, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am J Respir Crit Care Med. 153:1996;1781-1784.
45. Fahy J.V., Wong H.H., Geppetti P., Reis J.M., Harris S.C., Maclean D.B., Nadel J.A., Boushey H.A. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Respir Crit Care Med. 152:1995;879-884.
46. Ichinose M., Miura M., Yamauchi H., Kageyama N., Tomaki M., Oyake T., Ohuchi Y., Hida W., Miki H., Tamura G., Shirato K. A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med. 153:1996;936-941.
47. van Schoor J., Joos G., Chasson B., Brouard R., Pauwels R. The effect of the NK2 receptor antagonist SR48968 (saredutant) on neurokinin A-induced bronchoconstrction in asthmatics. Eur Respir J. 12:1998;17-23.
48. Advenier C., Naline E., Toty L., Bakdach H., Edmonds-Alt X., Vilain P., BreliÅre J.-C., Le Fur G. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis. 146:1992;1177-1181.
49. Catalioto R.-M., Criscuoli M., Cucchi P., Giachetti A., Giannotti D., Giuliani S., Lecci A., Lippi A., Patacchini R., Quartara L., et al. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. Br J Pharmacol. 123:1998;81-91.
50. Naline E., Molimard M., Regoli D., Emonds-Alt X., Bellamy J.F., Advenier C. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. Am J Physiol. 271:1996;L763-L767.
51. Joos G.F., Lefebvre R.A., Kips J.C., Pauwels R.A. Tachykinins contract trachea from Fisher 344 rats by interaction with a tachykinin NK1 receptor. Eur J Pharmacol. 271:1994;47-54.
52. Diemunsch P., Grelot L. Potential of substance P antagonists as antiemetics. Drugs. 60:2000;533-546.
53. Advenier C., Lagente V., Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J. 10:1997;1892-1906.
54. Yang X.X., Powell W.S., Hojo M., Martin J.G. Hyperpnea-induced bronchoconstriction is dependent on tachykinin-induced cysteinyl leukotriene synthesis. J Appl Physiol. 82:1997;538-544.
55. Yoshihara S., Geppetti P., Hara M., Linden A., Ricciardolo F.L., Chan B., Nadel J.A. Cold air-induced bronchoconstriction is mediated by tachykinin and kinin release in guinea pigs. Eur J Pharmacol. 296:1996;291-296.
56. Pedersen K.E., Meeker S.N., Riccio M.M., Undem B.J. Selective stimulation of jugular ganglion afferent neurons in guinea pig airways by hypertonic saline. J Appl Physiol. 84:1998;499-506.
57. Piedimonte G., Hoffman J.I., Husseini W.K., Snider R.M., Desai M.C., Nadel J.A. NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways. J Appl Physiol. 74:1993;2462-2468.
58. Yoshihara S., Chan B., Yamawaki I., Geppetti P., Ricciardolo F.L.M., Massion P.P., Nadel J.A. Plasma extravasation in the rat trachea induced by cold air is mediated by tachykinin release from sensory nerves. Am J Respir Crit Care Med. 151:1995;1011-1017.
59. Wu Z.X., Lee L.Y. Airway hyperresponsiveness induced by chronic exposure to cigarette smoke in guinea pigs: role of tachykinins. J Appl Physiol. 87:1999;1621-1628.
60. Kraneveld A.D., Nijkamp F.P., Van Oosterhout A.J.M. Role of neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. Am J Respir Crit Care Med. 156:1997;367-374.
61. De Vries A., Dessing M.C., Engels F., Henricks P.A., Nijkamp F.P. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med. 159:1999;1541-1544.
62. 2 muscarinic receptor function in antigen challenged guinea-pigs. Br J Pharmacol. 124:1998;267-276.
63. Hoshino H., Lötvall J., Skoogh B.-E., Linden A. Neutrophil recruitment by interleukin-17 into rat airways in vivo. Am J Respir Crit Care Med. 159:1999;1423-1428.
64. Jacoby D.B., Yost B.L., Elwood T., Fryer A.D. Effects of neurokinin receptor antagonists in virus-infected airways. Am J Physiol - Lung Cell Mol Physiol. 279:2000;L59-L65.
65. Moreaux B., Nemmar A., Vincke G., Halloy D., Beerens D., Advenier C., Gustin P. Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur J Pharmacol. 408:2000;305-312.
66. Ricciardolo F.L.M., Rado V., Fabbri L.M., Sterk P.J., Di Maria G.U., Geppetti P. Bronchoconstriction induced by citric acid inhalation by guinea pigs. Am J Respir Crit Care Med. 159:1999;557-562.